Results 91 to 100 of about 3,401 (184)

Delimiting MOGAD as a disease entity using translational imaging. [PDF]

Front Neurol, 2023
Oertel FC, Hastermann M, Paul F.
europepmc   +1 more source

Me, Myself, and Not-I: Self-Discrepancy Type Predicts Avatar Creation Style. [PDF]

Front Psychol, 2020
Loewen MGH, Burris CT, Nacke LE.
europepmc   +1 more source

Evaluation of Scalability and Communication in MMOGs [PDF]

Massively Multiplayer Online Games (MMOGs) can involve millions of synchronous players scattered across the world and participating with each other within a single shared game.
Abdulazeez, S, Al-Jumeily, D, El Rhalibi, A   +2 more
core  

Learning through playing for or against each other? Promoting collaborative learning in digital game based learning [PDF]

The process of learning through Game Based Learning (GBL) presents both positive aspects and challenges to be faced in order to support the achievement of learning goals and knowledge creation.
Earp, Jeffrey, Mireia, Usart, Ott, Michela, Romero, Margarida   +3 more
core  

Proinsulin-Loaded Nanoparticles Suppress Insulitis and Induce Temporary Diabetes Remission. [PDF]

Cells
Agapoff M, Dubreil C, Waeckel-Énée E, Geinguenaud F, Manceau V, Diana J, Bertocci B, Motte L, van Endert P.   +8 more
europepmc   +1 more source

Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review. [PDF]

Int J Mol Sci, 2023
Tanaka K, Kezuka T, Ishikawa H, Tanaka M, Sakimura K, Abe M, Kawamura M.   +6 more
europepmc   +1 more source

Patient-Derived Monoclonal Myelin Oligodendrocyte Glycoprotein Autoantibodies Mediate Cytotoxicity. [PDF]

Neurol Neuroimmunol Neuroinflamm
Wetzel NS, Kulsvehagen L, Lecourt AC, Filipek B, Lipps P, Rieder L, Berve K, Krishnamoorthy G, 't Hart BA, Schirmer L, Yandamuri SS, O'Connor KC, Pröbstel AK.   +12 more
europepmc   +1 more source

Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein. [PDF]

Fluids Barriers CNS
Cuypers ML, Jaspers T, Clerckx J, Leekens S, Cawthorne C, Bormans G, Cleeren F, Geukens N, De Strooper B, Dewilde M.   +9 more
europepmc   +1 more source

A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury. [PDF]

J Neuroinflammation, 2019
Vandenbark AA, Meza-Romero R, Benedek G, Offner H.   +3 more
europepmc   +1 more source

A Novel Partial MHC Class II Construct, DRmQ, Inhibits Central and Peripheral Inflammatory Responses to Promote Neuroprotection in Experimental Stroke. [PDF]

Transl Stroke Res, 2020
Lee JY, Castelli V, Bonsack B, Coats AB, Navarro-Torres L, Garcia-Sanchez J, Kingsbury C, Nguyen H, Vandenbark AA, Meza-Romero R, Offner H, Borlongan CV.   +11 more
europepmc   +1 more source